Literature DB >> 29914717

Future directions for medication assisted treatment for opioid use disorder with American Indian/Alaska Natives.

Kamilla L Venner1, Dennis M Donovan2, Aimee N C Campbell3, Dennis C Wendt2, Traci Rieckmann4, Sandra M Radin2, Sandra L Momper5, Carmen L Rosa6.   

Abstract

The U.S. is experiencing an alarming opioid epidemic, and although American Indians and Alaska Natives (AI/ANs) are especially hard hit, there is a paucity of opioid-related treatment research with these communities. AI/ANs are second only to Whites in the U.S. for overdose mortality. Thus, the National Institute on Drug Abuse convened a meeting of key stakeholders to elicit feedback on the acceptability and uptake of medication assisted treatment (MAT) for opioid use disorders (OUDs) among AI/ANs. Five themes from this one-day meeting emerged: 1) the mismatch between Western secular and reductionistic medicine and the AI/AN holistic healing tradition; 2) the need to integrate MAT into AI/AN traditional healing; 3) the conflict between standardized MAT delivery and the traditional AI/AN desire for healing to include being medicine free; 4) systemic barriers; and 5) the need to improve research with AI/ANs using culturally relevant methods. Discussion is organized around key implementation strategies informed by these themes and necessary for the successful adoption of MAT in AI/AN communities: 1) type of medication; 2) educational interventions; 3) coordination of care; and 4) adjunctive psychosocial counseling. Using a community-based participatory research approach is consistent with a "two eyed seeing" approach that integrates Western and Indigenous worldviews. Such an approach is needed to develop impactful research in collaboration with AI/AN communities to address OUD health disparities.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  American Indians/Alaska Natives; Implementation; Indigenous; Medication-assisted treatment; Opioid use disorder; Two-eyed seeing

Year:  2018        PMID: 29914717      PMCID: PMC6129390          DOI: 10.1016/j.addbeh.2018.05.017

Source DB:  PubMed          Journal:  Addict Behav        ISSN: 0306-4603            Impact factor:   3.913


  47 in total

1.  The science and practice of medication-assisted treatments for opioid dependence.

Authors:  Anna Pecoraro; Michelle Ma; George E Woody
Journal:  Subst Use Misuse       Date:  2012 Jun-Jul       Impact factor: 2.164

2.  Indigenous ways of knowing: implications for participatory research and community.

Authors:  Patricia A L Cochran; Catherine A Marshall; Carmen Garcia-Downing; Elizabeth Kendall; Doris Cook; Laurie McCubbin; Reva Mariah S Gover
Journal:  Am J Public Health       Date:  2007-11-29       Impact factor: 9.308

3.  Developing a participatory Aboriginal health research project: "Only if it's going to mean something".

Authors:  Kristen Jacklin; Phyllis Kinoshameg
Journal:  J Empir Res Hum Res Ethics       Date:  2008-06       Impact factor: 1.742

4.  A multi-level analysis of counselor attitudes toward the use of buprenorphine in substance abuse treatment.

Authors:  Traci R Rieckmann; Anne E Kovas; Bentson H McFarland; Amanda J Abraham
Journal:  J Subst Abuse Treat       Date:  2011-08-06

5.  Medical cannabis access, use, and substitution for prescription opioids and other substances: A survey of authorized medical cannabis patients.

Authors:  Philippe Lucas; Zach Walsh
Journal:  Int J Drug Policy       Date:  2017-02-09

6.  Community-wide measures of wellness in a remote First Nations community experiencing opioid dependence: evaluating outpatient buprenorphine-naloxone substitution therapy in the context of a First Nations healing program.

Authors:  Dinah Kanate; David Folk; Sharon Cirone; Janet Gordon; Mike Kirlew; Terri Veale; Natalie Bocking; Sara Rea; Len Kelly
Journal:  Can Fam Physician       Date:  2015-02       Impact factor: 3.275

7.  Reconceptualizing native women's health: an "indigenist" stress-coping model.

Authors:  Karina L Walters; Jane M Simoni
Journal:  Am J Public Health       Date:  2002-04       Impact factor: 9.308

8.  Evaluation of 6 remote First Nations community-based buprenorphine programs in northwestern Ontario: Retrospective study.

Authors:  Solomon Mamakwa; Meldon Kahan; Dinah Kanate; Mike Kirlew; David Folk; Sharon Cirone; Sara Rea; Pierre Parsons; Craig Edwards; Janet Gordon; Fiona Main; Len Kelly
Journal:  Can Fam Physician       Date:  2017-02       Impact factor: 3.275

9.  Rate of methadone use among Aboriginal opioid injection drug users.

Authors:  Evan Wood; Julio S Montaner; Kathy Li; Lucy Barney; Mark W Tyndall; Thomas Kerr
Journal:  CMAJ       Date:  2007-07-03       Impact factor: 8.262

Review 10.  Advances in the treatment of opioid use disorders.

Authors:  George E Woody
Journal:  F1000Res       Date:  2017-01-27
View more
  24 in total

1.  Substance Use Research with Indigenous Communities: Exploring and Extending Foundational Principles of Community Psychology.

Authors:  Dennis C Wendt; William E Hartmann; James Allen; Jacob A Burack; Billy Charles; Elizabeth J D'Amico; Colleen A Dell; Daniel L Dickerson; Dennis M Donovan; Joseph P Gone; Roisin M O'Connor; Sandra M Radin; Stacy M Rasmus; Kamilla L Venner; Melissa L Walls
Journal:  Am J Community Psychol       Date:  2019-07-31

2.  Trends in Indicators of Injection Drug Use, Indian Health Service, 2010-2014 : A Study of Health Care Encounter Data.

Authors:  Mary E Evans; Marissa Person; Brigg Reilley; Jessica Leston; Richard Haverkate; Jeffrey T McCollum; Andria Apostolou; Michele K Bohm; Michelle Van Handel; Danae Bixler; Andrew J Mitsch; Dana L Haberling; Sarah M Hatcher; Thomas Weiser; Kim Elmore; Eyasu H Teshale; Paul J Weidle; Philip J Peters; Kate Buchacz
Journal:  Public Health Rep       Date:  2020-07-07       Impact factor: 2.792

3.  Comparing the feasibility of four web-based recruitment strategies to evaluate the treatment preferences of rural and urban adults who misuse non-prescribed opioids.

Authors:  Elizabeth C Saunders; Alan J Budney; Patricia Cavazos-Rehg; Emily Scherer; Lisa A Marsch
Journal:  Prev Med       Date:  2021-09-07       Impact factor: 4.018

4.  Dual mental health diagnoses predict the receipt of medication-assisted opioid treatment: Associations moderated by state Medicaid expansion status, race/ethnicity and gender, and year.

Authors:  George Pro; Jeff Utter; Shane Haberstroh; Julie A Baldwin
Journal:  Drug Alcohol Depend       Date:  2020-03-07       Impact factor: 4.492

5.  Motivational interviewing and culture for urban Native American youth (MICUNAY): A randomized controlled trial.

Authors:  Elizabeth J D'Amico; Daniel L Dickerson; Ryan A Brown; Carrie L Johnson; David J Klein; Denis Agniel
Journal:  J Subst Abuse Treat       Date:  2019-12-28

6.  Quantifying opioid use disorder Cascade of Care outcomes in an American Indian tribal nation in Minnesota.

Authors:  Thaius Boyd; Jordan Stipek; Alex Kraft; Judge Muskrat; Kevin A Hallgren; Clinton Alexander; Brenna Greenfield
Journal:  Drug Alcohol Depend       Date:  2021-03-18       Impact factor: 4.492

7.  Trends in Non-Medical Prescription Opioid Use among Urban and Rural American Indian and Alaska Native Youth Residing in New Mexico: 2013-2017.

Authors:  Katherine Hirchak; Solmaz Amiri; Judith Espinoza; Jalene Herron; Alexandra Hernandez-Vallant; Violette Cloud; Kamilla Venner
Journal:  Am Indian Alsk Native Ment Health Res       Date:  2021

8.  Medication for Adolescents and Young Adults With Opioid Use Disorder.

Authors: 
Journal:  J Adolesc Health       Date:  2021-01-21       Impact factor: 5.012

9.  Development of an unannounced standardized patient protocol to evaluate opioid use disorder treatment in pregnancy for American Indian and rural communities.

Authors:  A Taylor Kelley; Marcela C Smid; Jacob D Baylis; Elizabeth Charron; Amy E Binns-Calvey; Shayla Archer; Saul J Weiner; Lori Jo Begaye; Gerald Cochran
Journal:  Addict Sci Clin Pract       Date:  2021-06-25

10.  How is Etuaptmumk/Two-Eyed Seeing characterized in Indigenous health research? A scoping review.

Authors:  Sophie I G Roher; Ziwa Yu; Debbie H Martin; Anita C Benoit
Journal:  PLoS One       Date:  2021-07-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.